Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Hydroxyurea IP 500 mg Capsule
Therapeutic Category
Oncology, Anticancer
Dosage Form
Capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
HYDROCLUB 500 Capsule (Hydroxyurea IP 500 mg) is a crucial oral medication that holds significant importance across two critical therapeutic areas: Oncology and Hematology. It is an antimetabolite and a potent inhibitor of ribonucleotide reductase, the enzyme essential for DNA synthesis.
Oncology: It is widely used to treat Chronic Myeloid Leukemia (CML), where it helps control the proliferation of white blood cells. It is also combined with radiation therapy to manage Head and Neck Cancer (advanced squamous cell carcinoma).
Hematology (Sickle Cell Anemia - SCA): At lower doses, Hydroxyurea is the established standard of care for adults and children with SCA. It works by increasing the production of fetal hemoglobin (HbF), which helps to keep red blood cells round and flexible, drastically reducing the frequency of painful vaso-occlusive crises and the need for blood transfusions.
The consistent and long-term dosing required for both CML and SCA, coupled with the critical nature of these diseases, ensures a stable and high-demand market for Hydroxyurea 500 mg capsules.
We offer a high-value PCD Pharma Franchise opportunity for HYDROCLUB 500. By partnering with us, you gain Monopoly Rights in your territory, allowing you to penetrate both the specialized oncology/hematology centers and general retail channels with a product of proven efficacy and market stability.
May cause headache, muscle pain, nausea, abdominal discomfort, or mild liver enzyme elevation. Rarely, serious muscle problems (myopathy or rhabdomyolysis) may occur.
Primary hypercholesterolemia Mixed dyslipidemia Familial hypercholesterolemia Prevention of cardiovascular disease in high-risk patients
Take under medical supervision, preferably once daily, with or without food. Regular liver function and lipid profile monitoring is advised. Inform your doctor about any muscle pain, weakness, or pre-existing liver/kidney conditions. Avoid excessive alcohol intake.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin 5 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Hydroxyurea 500mg Capsule is an antimetabolite medicine used mainly in blood disorders like sickle cell anemia and certain hematological conditions, making it a specialized prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in sickle cell disease, thalassemia-related complications, chronic myeloproliferative disorders, and oncology/hematology treatment protocols. It is commonly prescribed by hematologists and specialists for long-term management of blood disorders.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Hydroxyurea IP 500mg Capsule with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady specialty prescription demand, hospital-based usage, and long-term chronic treatment cycles when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hematology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.